Clinical Exome Solution (CES v3)

The NGS Clinical Exome Solution (CES v3) of SOPHiA GENETICS covers the coding regions (± 5 bp of intronic regions) of 4,728 genes, the entire mitochondrial genome and ~200 non-coding variants with known pathogenicity in deep introns/enhancer/promoter genes. This new and improved probe design of the v3 provides increased capacity for detection of rare and inherited disorders.

  • Accurate analysis of multiple type of variants (SNVs, Indels and CNVs).
  • High on-target reads percentage and coverage uniformity even in GC-rich regions.

With the clinical exome study for clinical diagnosis, mutations in genes not related to the clinical phenotype of the patient but with clinical relevance can be detected. Exome sequencing thus helps early detection and early treatment of this genetic diseases.

CES v3 offers a streamlined end-to-end workflow (from sample to variant report), making it faster and easier to assessment of challenging Mendelian disorders, freeing up time and resources.

flujo
Clinical Exome Solution (CES v3) 8

This NGS solution includes a capture-based target enrichment kit, as well as the functionality and analytical capabilities of the SOPHiA DDM™ platform for data interpretation.

The SOPHiA DDM™ platform features intuitive variant filters and prioritization options to streamline the interpretation process and help you greatly reduce turnaround time.

2
  • GRCh38/hg38-based analytics for accurate variant annotation.
  • Dual Variant Pre-classification to improve assessment of variants pathogenicity based on both ACMG scores and our machine learning-based predictions
  • Virtual Panel to restrict the interpretation to sub-panels of genes using the HPO or OMIM browser
  • Cascading Filters to apply custom filtering options for quicker screening of relevant variants and save strategies for future analyses
  • Familial Variant Analysis (trio-analysis) to quickly identify causative variants by selecting different inheritance modes with a single mouse click to shorten the candidate variant list accordingly

Through SOPHiA DDM™, you can also have access to Alamut Visual Plus, a full-genome browser that integrates numerous curated genomic and literature databases, guidelines, missense and slicing predictors, thus enabling a deeper variant exploration.

In addition to the Clinical Exome kit, we have other more specific panels for clinical diagnosis in areas such as metabolism, oncology, genetics or cardiology.

Area:

Exomes, Molecular Genetics
Consult our experts

Google reCaptcha: Invalid site key.

Related products

SOPHiA DDM GEN2

Analytical platform for clinical genomics that enables the detection, annotation, and interpretation of genomic variants using artificial intelligence to support patient diagnosis and treatment. Detailed Description SOPHiA DDM™ Platform is an advanced solution for precision medicine workflows, with a renewed interface, web access, and new functionalities to accelerate genomic data analysis. It offers end‑to‑end workflows…
SOPHIA Genetics

PGT-SR (Preimplantation Genetic Testing for Chromosomal Structural Rearrangements)

PGT‑SR (Preimplantation Genetic Testing for Structural Chromosomal Rearrangements) is a solution aimed at the analysis of structural chromosomal rearrangements in embryos. According to the product literature, it is based on single‑cell whole‑genome amplification and NGS sequencing to detect embryos from patients with chromosomal abnormalities and select euploid embryos for transfer, with the aim of reducing…
Yikon Genomics
Next Generation Sequencing (NGS)

MaReCs (Mapping allele with resolved carrier state test)

MaReCs® (Allelic Mapping with Resolved Carrier Status) is a PGT‑SR technology that first identifies aneuploid or euploid embryos and then analyses translocation breakpoints and SNP linkage to differentiate carrier from non‑carrier euploid embryos. Detailed Description Principle of operation MaReCs® combines ChromSwift® technology with NGS sequencing to perform a CNV analysis and subsequently an SNP linkage…
Yikon Genomics
Next Generation Sequencing (NGS)

KaryoSeq (Integrated solution for PGT-M, PGT-SR and PGT-A)

KaryoSeq™ is a next‑generation sequencing (NGS)‑based solution for preimplantation genetic testing that enables PGT‑M, PGT‑SR and PGT‑A within a single workflow. It is designed for the analysis of DNA extracted from 3 to 10 trophectoderm cells of human embryos at the blastocyst stage. Detailed Description Principle of operation KaryoSeq™ is based on the MARSALA principle…
Yikon Genomics
Next Generation Sequencing (NGS)